Overview
For 30 years Drugs & Aging has been delivering essential information on the most important aspects of drug therapy to researchers and healthcare professionals involved in the care of older patients.
Through a program of reviews and original research articles, the journal addresses major issues relating to drug therapy in older adults, including the management of specific diseases or disorders, particularly those associated with aging, age-related physiological changes impacting drug therapy, and issues related to drug utilization and prescribing.
As a hybrid journal, Drugs & Aging does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).
Drugs & Aging offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).
- Editor
-
- Caroline Herdson
- Journal Impact Factor
- 3.4 (2023)
- 5-year Journal Impact Factor
- 3.5 (2023)
- Submission to first decision (median)
- 11 days
- Downloads
- 451,481 (2023)
Latest articles
Journal updates
-
Digital Features
Drugs & Aging is able to host a range of digital features, with a number of options available to authors.
Journal information
- Electronic ISSN
- 1179-1969
- Print ISSN
- 1170-229X
- Abstracted and indexed in
-
- ANVUR
- BFI List
- BIOSIS
- Baidu
- CAB Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- Current Contents/Life Sciences
- Dimensions
- EBSCO
- EMBASE
- EMCare
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information